Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR(®)) Monotherapy in Adults and Children with Partial-Onset Seizures: Exposure-Response Modeling and Simulation

PURPOSE: We conducted exposure-response modeling and simulations to compare the predicted efficacy of extended-release oxcarbazepine (OXC-XR), an oral once-daily (qd) antiepileptic drug, with that of immediate-release (IR) OXC twice-daily (bid) when the agents are used as monotherapy or adjunctive t...

Descripción completa

Detalles Bibliográficos
Autores principales: Faison, Shamia, Gomeni, Roberto, Mendes, Shannon, O’Neal, Welton, Schwabe, Stefan, Nasser, Azmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520464/
https://www.ncbi.nlm.nih.gov/pubmed/33061671
http://dx.doi.org/10.2147/CPAA.S256972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520464/
https://www.ncbi.nlm.nih.gov/pubmed/33061671
http://dx.doi.org/10.2147/CPAA.S256972

Ejemplares similares